SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Kosan BioSciences -- KOSN
An SI Board Since May 2001
Posts SubjectMarks Bans Symbol
933 40 0 KOSN
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
683dtp.nci.nih.gov for the Kosan folder, nothing new, graphics just look neatMike McFarland-4/25/2006
682<i>personally, I find this simply repugnant.</i> Agree. Heck, it’s DewDiligence_on_SI-4/21/2006
681From the Proxy: <i> The Company’s current policy does not require directormopgcw-4/21/2006
680[Inhibition of HSP70 & HSP90 yields additive antitumor activity] >>Catuck-4/20/2006
679Placed here for info re: HSP90 Scientists Reveal First Ever Complete StructureLJM-4/20/2006
678[DMAG and MEK inhibitors in Gleevec resistant, Bcr/Abl positive leukemias] >tuck-4/17/2006
677Infinity reverses into a public quote (& more cash...) - Message 22350613nigel bates-4/12/2006
676Great Point Partners, LLC has filed an SC 13 G for 2,245,715 shares representingIcebrg-4/12/2006
675Kosan to Present Data at AACR on HSP90 Inhibitors, KOS-953 and KOS-1022, and Epomopgcw-4/3/2006
674List of abstracts for the Cold Spring Harbour meeting - meetings.cshl.edu - wonigel bates-3/31/2006
673hsp90 labs community.acs.org meetings hsp90.org meetings.cshl.eduMike McFarland-3/30/2006
672LOL. thank you. (eom)mopgcw-3/30/2006
671Most probably because they could. ErikIcebrg-3/30/2006
670WHY??? arghh.mopgcw-3/30/2006
6695 million share offering at $5: >>HAYWARD, Calif., March 30 /PRNewswire-Ftuck-3/30/2006
668<<27-Mar-2006 Entry into a Material Definitive Agreement, Other Events Ihmpa-3/27/2006
667(HSP 90) Progress report on Mycograb from Neutec's results announcement: &nigel bates-3/27/2006
666Entry into a Material Definitive Agreement Item 1.01. Entry into a Material DefIcebrg-3/24/2006
665[17-DMAG & 17-AAG inhibit tumor angiogenesis via VEGF receptors] >>Motuck-3/21/2006
664[17-DMAG & 17-AAG: mechanism of toxicity involves thiol groups of critical ctuck-3/21/2006
663[Targeted covalent inactivation of protein kinases by resorcylic acid lactone potuck-3/17/2006
662[17-AAG as radiation sensitizer] >>J Clin Endocrinol Metab. 2006 Mar 14; tuck-3/17/2006
661Kosan Reports 2005 Fourth Quarter and Year End Results Thursday March 2, 7:30 ammopgcw-3/6/2006
660AACR, 17-AAG and Arsenic trioxide Abstract Number: 4933 Presentation Title: Syzeta1961-3/5/2006
659Maybe looking interesting at this level & post 'restructuring' ? Bunigel bates-3/2/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News